Tactile Systems Technology (NASDAQ:TCMD) Shares Gap Down on Analyst Downgrade

Shares of Tactile Systems Technology, Inc. (NASDAQ:TCMD) gapped down prior to trading on Tuesday after BTIG Research lowered their price target on the stock from $35.00 to $31.00. The stock had previously closed at $22.87, but opened at $21.54. BTIG Research currently has a buy rating on the stock. Tactile Systems Technology shares last traded at $23.7580, with a volume of 54,576 shares traded.

TCMD has been the topic of several other research reports. Wall Street Zen upgraded Tactile Systems Technology from a “buy” rating to a “strong-buy” rating in a research note on Saturday. Weiss Ratings upgraded Tactile Systems Technology from a “hold (c)” rating to a “hold (c+)” rating in a research note on Tuesday, October 13th. Four research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $36.80.

Insider Buying and Selling

In other news, CEO Sheri Dodd sold 10,978 shares of the company’s stock in a transaction on Monday, August 10th. The shares were sold at an average price of $29.44, for a total value of $323,192.32. Following the sale, the chief executive officer directly owned 232,907 shares of the company’s stock, valued at $6,856,782.08. This represents a 4.50% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders own 2.10% of the company’s stock.

Tactile Systems Technology News Summary

Here are the key news stories impacting Tactile Systems Technology this week:

• Positive Sentiment: Third-quarter adjusted earnings were $0.31 per share, above the $0.28 consensus estimate. Revenue was $91.86 million, essentially in line with the $91.99 million estimate. Tactile Systems Technology quarterly earnings report
• Positive Sentiment: The core lymphedema business continued to expand, with product revenue rising 13% year over year to $81.8 million. Management also said technology improvements cut medical-record review times by roughly 50%, potentially supporting operating efficiency over time. Tactile Systems long-term investor takeaways
• Positive Sentiment: BTIG Research maintained a Buy rating and continues to see substantial upside, although it lowered its price target from $35 to $31. Wall Street Zen also upgraded its rating on TCMD. BTIG Research rating
• Neutral Sentiment: Tactile Medical reaffirmed fiscal 2026 revenue guidance of $360 million to $366 million, a range that broadly brackets the $362.5 million analyst consensus. This suggests expectations remain intact but does not represent a clear forecast upgrade.
• Negative Sentiment: The smaller AffloVest airway-clearance business continued to contract, while inventory challenges deepened. Higher sales and administrative expenses also pushed operating income below the prior-year level, and quarterly EPS declined from $0.36 a year earlier. Tactile Medical earnings analysis
• Negative Sentiment: The reduction in BTIG’s target price signals more cautious near-term expectations despite the continued Buy rating. Investors may therefore focus on whether lymphedema growth can offset AffloVest weakness and spending pressure.

Institutional Inflows and Outflows

Several institutional investors have recently made changes to their positions in TCMD. BlackRock Inc. acquired a new position in Tactile Systems Technology during the second quarter valued at $56,733,000. First Light Asset Management LLC purchased a new stake in Tactile Systems Technology in the second quarter valued at $13,775,000. Renaissance Technologies LLC grew its position in Tactile Systems Technology by 32.3% during the 1st quarter. Renaissance Technologies LLC now owns 510,897 shares of the company’s stock worth $13,350,000 after purchasing an additional 124,597 shares during the period. Jupiter Topco LLC acquired a new stake in Tactile Systems Technology during the 2nd quarter worth about $11,831,000. Finally, Punch & Associates Investment Management Inc. acquired a new stake in Tactile Systems Technology during the 2nd quarter worth about $9,381,000. Hedge funds and other institutional investors own 83.43% of the company’s stock.

Tactile Systems Technology Stock Performance

The stock has a 50 day simple moving average of $22.72 and a two-hundred day simple moving average of $25.91. The firm has a market cap of $539.52 million, a PE ratio of 22.06 and a beta of 0.82.

Tactile Systems Technology (NASDAQ:TCMD) last issued its quarterly earnings data on Monday, November 2nd. The company reported $0.31 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.28 by $0.03. The business had revenue of $91.86 million during the quarter, compared to analysts’ expectations of $91.99 million. Tactile Systems Technology had a return on equity of 11.49% and a net margin of 7.10%. Equities research analysts forecast that Tactile Systems Technology, Inc. will post 1.10 earnings per share for the current year.

About Tactile Systems Technology

Tactile Systems Technology, doing business as Tactile Medical, develops and provides medical devices and services for people with chronic swelling and related conditions. The company focuses primarily on lymphedema and chronic venous insufficiency, conditions that can cause persistent fluid buildup in the limbs and trunk.

Its principal products include advanced pneumatic compression devices, such as the Flexitouch Plus system for the treatment of lymphedema and the Entre Plus system for home treatment of lymphedema and chronic venous insufficiency.